Rapid detection of cytomegalovirus infection in transplant patients

References

• Stagno S, Reynolds DW, Huang ES, Thames SD, Smith RJ, Alford CA. Congenital cytomegalovirus infection. N Engl. Merl 296,1254–1258 (1977).
   PubMed Web of Science ®Google Scholar
• Vancikova Z, Dvorak P. Cytomegalovirus infection in immunocompetent and immunocompromised individuals: a review. Gum Drug Targets Immune Enclocr. Metabol Disord. 1,179–187 (2001).
   PubMedGoogle Scholar
• Paya CV. Economic impact of cytomegalovirus in solid organ transplantation. Transpl. Infect. Dis. 3\(Suppl. 2), 14–19 (2001).
   Google Scholar
• Rubin RII. Importance of CMV in the transplant population. Tramp]. Infect. Dis. 1 (Suppl. 1), 3–7 (1999).
   Google Scholar
• Emery VC. Cytomegalovirus and the aging population. Drugs Aging18, 927–933 (2001).
   PubMedGoogle Scholar
• Aubert G, Hassan-Walker AF, Madrigal JA etal Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants. J. Infect. Dis. 184,955–963 (2001).
   PubMed Web of Science ®Google Scholar
• Taylor GH. Cytomegalovirus. Am. Fain. Physician 67,519–524 (2003).
   PubMedGoogle Scholar
• Grundy JE. Virologic and pathogenetic aspects of cytomegalovirus infection. Rev Infect. Dis. 12 (Suppl. 7), S711—S719 (1990).
   Google Scholar
• Emery VC, Hassan-Walker AF, Burroughs AK, Griffiths PD. Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts. Infect. Dis. 15(185), 1723–1728 (2002).
   Google Scholar
• •Human cytomegalovirus (HCMV) rates of replication in HCMV-naive patients are higher as compared with CMV-experienced transplant patients. Data suggests that an anti-HCMV drug or vaccine with an efficacy of more than 93% is required to eliminate viral growth during infection of HCMV-naive liver transplant recipients, whereas lower efficacy levels are sufficient to reduce replication in hosts with prior HCMV immunity. toLeung AK, Sauve RS, Davies HD. Congenital cytomegalovirus infection. Natl Merl Assoc. 95,213-218 (2003).
   Google Scholar
• Halwachs-Baumann G, Genser B, Pailer S etal Human cytomegalovirus load in various body fluids of congenitally infected newborns.' Gun. Viral. 25, S81—S87 (2002).
   Google Scholar
• Schafer P, Tenschert W, Cremaschi L, Schroter M, Gutensohn K, Laufs R. Cytomegalovirus cultured from different major leukocyte subpopulations: association with clinical features in CMV immunoglobulin G-positive renal allograft recipients.' Merl Vim. 61,488–496 (2000).
   PubMedGoogle Scholar
• Boeckh M, Bowden RA, Goodrich JM, Pettinger M, Meyers JD. Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. B/ooc/80,1358–1364 (1992).
   Google Scholar
• The TH, van der Ploeg M, van den Berg AP et al Direct detection of cytomegalovirus in peripheral blood leukocytes: a review of the antigenemia assay and polymerase chain reaction. Transplantation 54,193–198 (1992).
   PubMed Web of Science ®Google Scholar
• Mazzulli T, Drew LW, Yen-Lieberman B etal Multicenter comparison of the Digene hybrid capture CMV DNA assay (version 2.0), the pp65 antigenemia assay and cell culture for detection of cytomegalovirus viremia. j Clin. Microbial. 37,958-963 (1999).
   Google Scholar
• Gema G, Furione M, Baldanti F, Sarasini A. Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients. j Clin. Microbial. 32, 2709–2717 (1994).
   PubMedGoogle Scholar
• Landry ML, Ferguson D. Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease. j Clin. Nlicrobiol 31, 2851–2856 (1993).
   PubMed Web of Science ®Google Scholar
• Gerna G, Percivalle E, Torsellini M, Revello MG. Standardization of the human cytomegalovirus antigenemia assay by means of in vitro-generated pp65-positive peripheral blood polymorphonuclear leukocytes. j Clin. Microbial. 36, 3585–3589 (1998).
   Google Scholar
• Locatelli F, Percivalle E, Comoli P etal Human cytomegalovirus (HCMV) infection in paediatric patients given allogeneic bone marrow transplantation: role of early antiviral treatment for HCMV antigenaemia on patients' outcome. Br. 1-Lematol. 88,64-71 (1994).
   Google Scholar
• Schafer P, Tenschert W Gutensohn K, Laufs R. Minimal effect of delayed sample processing on results of quantitative PCR for cytomegalovirus DNA in leukocytes compared with results of an antigenemia assay. j din. Microbial. 35,741–744 (1997).
   Google Scholar
• Gema G, Furione M, Baldanti F, Percivalle E, Comoli P, Locatelli Quantitation of human cytomegalovirus DNA in bone marrow transplant recipients. Br. 1-Lematol. 91,674-683 (1995).
   Google Scholar
• Boivin G, Handfield J, Murray G etal Quantitation of cytomegalovirus (CMV) DNA in leukocytes of human immunodeficiency virus-infected subjects with and without CMV disease by using PCR and the SHARP Signal Detection System. 1 Clin. Microbial. 35,525-526 (1997).
   Google Scholar
• Zhang LJ, Hanff P, Rutherford C, Churchill WH, Crumpacker CS. Detection of human cytomegalovirus DNA, RNA and antibody in normal donor blood. Infect. Dis. 171(4), 1002–1006 (1995).
   Google Scholar
• Larsson S, Soderberg-Naucler C, Wang FZ, Moller E. Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors overtime. liansfusion 38,271–278 (1998).
   PubMed Web of Science ®Google Scholar
• Weber B, Fall EM, Berger A, Doerr HW. Screening of blood donors for human cytomegalovirus (HCMV) IgG antibody with an enzyme immunoassay using recombinant antigens. j Clin. Viral. 14, 173–181 (1999).
   PubMedGoogle Scholar
• Landini MP, Mach M. Searching for antibodies specific for human cytomegalovirus: is it diagnostically useful? When and how. Scand j Infect. Dir. Suppl 99,18–23 (1995).
   PubMedGoogle Scholar
• Morris DJ, Klapper PE, Cleator G. Detection of false seroconversions in cytomegalovirus seronegative platelet donors by serial complement fixation or IgG-specific radioimmunosorbent tests. Viral. Methods 39,319–323 (1992).
   Google Scholar
• Hailing VW, Maine GT, Groettum CM etal Clinical evaluation of a new recombinant antigen-based cytomegalovirus immunoglobulin M immunoassay in liver transplant recipients. Transplantation 71,395–397 (2001).
   PubMedGoogle Scholar
• Barkholt LM, Ehrnst A, Veress B. Clinical use of immunohistopathologic methods for the diagnosis of cytomegalovirus hepatitis in human liver allograft biopsy specimens. Scand Castroenteml 29,553–560 (1994).
   Google Scholar
• Colina F, Juca NT, Moreno E etal Histological diagnosis of cytomegalovirus hepatitis in liver allografts. j din. Pathol 48,351–357 (1995).
   Google Scholar
• Espy MJ, Paya CV, Holley KE etal Diagnosis of cytomegalovirus hepatitis by histopathology and in situ hybridization in liver transplantation. Diagn. Microbial. Infect. Dis. 14,293–296 (1991).
   PubMedGoogle Scholar
• Paya CV, Holley KE, Wiesner RII etal Early diagnosis of cytomegalovirus hepatitis in liver transplant recipients: role of immunostaining, DNA hybridization and culture of hepatic tissue. Hepatology12, 119–126 (1990).
   PubMedGoogle Scholar
• Weiss LM, Movahed LA, Berry GJ, Billingham ME. In situ hybridization studies for viral nucleic acids in heart and lung allograft biopsies. Am. J. Clin. Pathol 93,675–679 (1990).
   PubMedGoogle Scholar
• Emery VC. The dynamics of human cytomegalovirus replication in vivo. J. Exp. Merl 190,177–182 (1999).
   PubMedGoogle Scholar
• ••Found that doubling time/half-life ofCMV in blood is approximately 1 day, showing that CMV DNA replication in ilvois a highly dynamic process and concludes that the reputation of CMV as a slowly replicating virus based on the time taken to produce cytopathic effects in vitro is unwarranted.
   Google Scholar
• Emery VC, Sabin CA, Cope AV eta]. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 355, 2032–2036 (2000).
   Google Scholar
• Barrett-Muir WY, Aitken C, Templeton K, Raftery M, Kelsey SM, Breuer J. Evaluation of the murex hybrid capture cytomegalovirus DNA assay versus plasma PCR and shell vial assay for diagnosis of human cytomegalovirus viremia in immunocompromised patients. Clin. Nlicrobiol 36(9), 2554–2556 (1998).
   Google Scholar
• •Discusses the enhanced sensitivity of the DNA Hybrid Capture Assay (HCA) and plasma PCR as a means to improve the diagnosis and management of CMV disease in CMV-seropositive patients. HCA and plasma PCR were more consistently positive than shell vial assay during viremic episodes.
   Google Scholar
• Schirm J, Kooistra A, van Son WJ etal Comparison of the Murex Hybrid Capture CMV DNA (v 2.0) assay and the pp65 CMV antigenemia test for the detection and quantitation of CMV in blood samples from immunocompromised patients. I Clin. Viral. 14(3), 153–165 (1999).
   Google Scholar
• Chemoff DN, Miner RC, Hoo BS etal Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched-DNA signal amplification assay. Clin. Nlicrobiol 35,2740–2744 (1997).
   PubMedGoogle Scholar
• Toyoda M, Carlos JB, Galera OA etal Correlation of cytomegalovirus DNA levels with response to antiviral therapy in cardiac and renal allograft recipients. Transplantation 63,957–963 (1997).
   PubMedGoogle Scholar
• Wu F, Li H, Zhang DY. Differential detection of cytomegalovirus immediate-early messenger RNA in clinical samples using ligation-dependent PCR. Mal. Diagn. 6,233–239 (2001).
   Google Scholar
• Degre M, Kristiansen KI, Rollag H, Holter E, Nordal IQ. Detection of human cytomegalovirus (HCMV) pp67-mRNA and pp65 antigenemia in relation to development of clinical HCMV disease in renal transplant recipients. Clin. Nlicrvbiol. Infect. 7,254-260 (2001).
   Google Scholar
• Hebart H, Rudolph T, Loeffler J etal Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation. Bone Marrow Transplant. 30(3), 181–187 (2002).
   Google Scholar
• Caliendo AM, Yen-Lieberman B, Baptista J et al Comparison of molecular tests for detection and quantification of cell-associated cytomegalovirus DNA. Clin. Microbial. 41,3509–3513 (2003).
   PubMedGoogle Scholar
• Hebart H, Muller C, Loffler J, Jahn G, Einsele H. Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation. Bone Marrow 71ansplant. 17,861-868 (1996).
   Google Scholar
• Sia IG, Wilson JA, Groettum CM, Espy MJ, Smith TF, Paya CV Evaluation of the COBAS Amplicor CMV Monitor test for detection of viral DNA in specimens taken from patients after liver transplantation. J. Clin. Microbial 38, 4356–4360 (2000).
   PubMedGoogle Scholar
• Pellegrin I, Garrigue I, Ekouevi D eta]. New molecular assays to predict occurrence of cytomegalovirus disease in renal transplant recipients. J. Infect. Dis. 182, 36–42 (2000).
   Google Scholar
• •Renal transplant patients were monitored weekly with CMV antigenemia, plasma qualitative Amplicor CMV, plasma and peripheral blood leukocyte (PBL) quantitative Amplicor CMV Monitor, PBL quantitative Quantiplex bDNA CMV version 2.0 and whole blood NucliSens pp67 assays. PBLs were positive before symptoms of CMV disease earlier than plasma or whole blood. PBL assays may be more appropriate than plasma assays when pre-emptive therapy is required to prevent the rapid progression from the first detection of the virus to CMV disease.
   Google Scholar
• Boeckh M, Gallez-Hawkins GM, Myerson D etal Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia and viral culture. 71ansplantation 64,108–113 (1997).
   Google Scholar
• Tong CY, Cuevas LE, Williams H, Bakran A. Prediction and diagnosis of cytomegalovirus disease in renal transplant recipients using qualitative and quantitative polymerase chain reaction. 71ansplantation 69,985–9891 (2000).
   Google Scholar
• ••Examines laboratory markers forpre-emptive antiviral therapy against CMV disease after transplantation. Both qualitative and quantitative PCR assays were used to monitor renal transplant recipients Qualitative leukocyte PCR was the best assay to predict CMV disease for R recipients who received R+ kidneys. Qualitative assays could not be used to guide pre-emptive therapy of R+ recipients, but plasma viral load and its incremental rate were diagnostic tools in R+ recipients.
   Google Scholar
• Razonable RR, Brown RA, Wilson J etal The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease. 7iansp/antation 73(6), 968–973 (2002).
   Google Scholar
• Caliendo AM, St George K, Kao SY etal Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype Amplicor CMV Monitor test in transplant recipients. j Clin. Nlicrobiol 38,2122–2127 (2000).
   PubMedGoogle Scholar
• •Excellent correlation between the quantitative PCR assay (Amplicor CMV Monitor test) and the CMV pp65 antigenemia assay was noted in transplant recipients.
   Google Scholar
• Griffiths PD, Cope AV, Hassan-Walker AF, Emery VC. Diagnostic approaches to cytomegalovirus infection in bone marrow and organ transplantation. Trawl Infect. Dir. 1,179–186 (1999).
   Google Scholar
• Humar A, Gregson D, Caliendo AM. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients. Transplantation 68,1305–1311 (1999).
   Google Scholar
• Mendez J, Espy M, Smith TF, Wilson J, Wiesner R, Paya CV. Clinical significance of viral load in the diagnosis of cytomegalovirus disease after liver transplantation. Transplantation 65, 1477–1481 (1998).
   PubMedGoogle Scholar
• Weinberg A, Hodges TN, Li S, Cai G, Zamora MR Comparison of PCR, antigenemia assay and rapid blood culture for detection and prevention of cytomegalovirus disease after lung transplantation. J. Clin. Nlicrobiol 38,768–772 (2000).
   PubMed Web of Science ®Google Scholar
• ••Evaluated utility of serial CMV bloodsamples with antigenemia, qualitative and
   Google Scholar